More than 80% of small businesses in the United States operate without employees, and many entrepreneurs thrive by staying solo. For others, it’s not a sustainable path. But deciding when and how to grow the team can be challenging.
Read More
Indianapolis-based Elevate, a nonprofit venture investment firm, has been operating under a cloud since late April when state officials froze its funding.
Read More
Now in its 23rd year, the Orr Fellowship program has helped develop an eye-popping number of leaders in Indiana’s tech and entrepreneurial ecosystems. It now counts 624 alumni who have worked at—and in some cases founded—nearly 300 significant companies and organizations.
Read More
The CEO of Indianapolis-based Elevate Ventures spills on expanding the search for talent, the untapped power of collaboration, and the five aspects of a business where entrepreneurs can minimize risk and attract investors.
Read More
Participants in the program via the Indiana Life Sciences Association can receive significant discounts—up to 75%—off list prices on goods including lab equipment, office supplies, corporate travel and insurance.
Artificial intelligence is making it less expensive to start and operate a company—and potentially reducing these startups’ reliance on venture funding.
Generations is set to be Indiana’s first minority depository institution—and one of only 153 operating in the United States and its territories. But the bank will be open to anyone.
In Pursuit Of Inc. plans to begin taking referrals early next year from area organizations helping men who are struggling to get their lives together.
The valuation reflects high expectations for the future of AI technology and continues OpenAI’s remarkable trajectory from its start as a nonprofit research lab in 2015.
BiomEdit said the disease it’s targeting, avian necrotic enteritis, causes an estimated $6 billion in annual losses worldwide.
The Wisconsin-based startup accelerator is shifting its conference strategy to one large gathering irather than a handful across the U.S., a move expected to expand networking opportunities among investors and entrepreneurs.
Syndeio Biosciences sees burgeoning potential to treat mental health and cognitive conditions, including Alzheimer’s and depression, with therapies that target the almost countless minuscule brain synapses that give people the ability to think and function.
IBJ talked with Heath last week during the Global Entrepreneurship Congress at the Indiana Convention Center about what IU Innovates has accomplished in its first two years and what’s next for the effort.
Almost exactly one year ago, Indiana officials publicly announced a significant entrepreneurial resource the state had been quietly working on for several years—the launch of a $100 million investment fund to help young companies scale up their businesses. A lot has changed since then.
IBJ strayed from its usual format last week to bring you our annual Innovation Issue, which this year featured 20 startup companies worth watching.
Even seasoned entrepreneurs and business executives have different takes about exactly what constitutes a startup—or at least a successful one.
Rob Mathews, executive director of Ball State University’s Entrepreneurship Center, views leadership and innovation as inseparable attributes for a startup.
Commerce Secretary David Adams announced last week that the state had frozen funds earmarked for Elevate Ventures, but he did not outline specific concerns about the nonprofit or its operations.
Evansville-based Old National Bank is working on a first-of-its-kind effort: the launch of an Indiana-based bank whose target customers are minorities and those underserved by traditional banks.
Chicago-based M25, a venture firm that invests in early-stage Midwestern tech startups, has named local entrepreneur Brian Powers as its Indianapolis-based venture partner.
The pre-clinical West Lafayette-based medical device startup is working to develop a new “microstructred” catheter to remove blood clots that cause strokes.
Kristin Sherman leads startup Kovina Therapeutics, which is still in the early stages of developing ways to stop human papillomavirus infections before cancer develops and to treat HPV cancers after detection.
Four-year-old Novusterra Inc. is planning an initial public offering within 90 days and hopes to be approved to trade on the OTCQB Venture Market, often used by companies that are still developing.
Insignum AgTech and Grannus Therapeutics were among the five winners announced Wednesday.
